Premium
Economics of chronic heart failure
Author(s) -
Berry Colin,
Murdoch David R.,
McMurray John J.V.
Publication year - 2001
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1016/s1388-9842(01)00123-4
Subject(s) - medicine , heart failure , health care , population ageing , intensive care medicine , indirect costs , total cost , economic cost , health economics , public health , population , environmental health , economic growth , economics , cardiology , nursing , neoclassical economics , accounting , microeconomics
Chronic heart failure (CHF) is now recognized as a major and escalating public health problem. The costs of this syndrome, both in economic and personal terms, are considerable. The prevalence of CHF is 1–2% and appears to be increasing, in part because of ageing of the population. Economic analyses of CHF should include both direct and indirect costs of care. Healthcare expenditure on CHF in developed countries consumes 1–2% of the total health care budget. The cost of hospitalization represents the greatest proportion of total expenditure. Optimization of drug therapy represents the most effective way of reducing costs. Recent economic analyses in the Netherlands and Sweden suggest the costs of care are rising.